Special Report: Will the COVID-19 Recovery Be Bumpier than Expected?
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Though IVD and commercial lab Q3 2023 earnings reports held promising signs, Q4 2024 and FY2023 results tell a different story.
From - Laboratory Industry Report
Children's Hospital Los Angeles (CHLA) has entered into a pact with Thermo Fisher Scientific to develop a panel of next-generation sequencing tests specifically for…
From - Laboratory Industry Report
Less than a year after launching its Watson Health unit, IBM (Armonk, N.Y.) has announced a fourth major health data-related acquisition…
From - Laboratory Industry Report
Walgreens has told Theranos to get its act together, or get out…
From - Laboratory Industry Report
San Diego-based Illumina has entered into biobanking deals with four major health care providers, allowing it to genotype tens of thousands of genetic specimens…